Optic
Optic Inc., an AI drug discovery company, creators of Bioptic.io — a proprietary ligand-based molecular search AI. Bioptic identifies small molecules by their activity-expressing fingerprints, assisting drug hunters in discovering a diverse set of candidates. Our pipeline includes three pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy.
Developer ToolsOpen SourceB2BEngineering, Product and Design
